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he JAMM (JAB1/MPN/Mov34 metalloenzyme) motif
has been proposed to provide the active site for
isopeptidase activity associated with the Rpn11/POH1
subunit of the 19S-proteasome and the Csn5-subunit of the
signalosome. We have looked for similar activity in associated
molecule with the SH3 domain of STAM (AMSH), a JAMM
domain–containing protein that associates with the SH3-
domain of STAM, a protein, which regulates receptor sorting
at the endosome. We demonstrate isopeptidase activity
against K48-linked tetraubiquitin and K63-linked poly-
ubiquitin chains to generate di-ubiquitin and free ubiquitin,
T
 
respectively. An inactivating mutation (D348A) in AMSH
leads to accumulation of ubiquitin on endosomes and the
concomitant stabilization of a ubiquitinated form of STAM,
which requires an intact ubiquitin interaction motif (UIM)
within STAM. Short interfering RNA knockdown of AMSH
enhances the degradation rate of EGF receptor (EGFR)
following acute stimulation and ubiquitinated EGFR provides
a substrate for AMSH in vitro. We propose that AMSH is a
deubiquitinating enzyme with functions at the endosome,
which oppose the ubiquitin-dependent sorting of receptors
to lysosomes.
 
Introduction
 
The signal for endosomal sorting of many receptors is the
covalent addition of ubiquitin mediated by a cognate E3 ligase.
This signal is recognized by the endosomal protein Hrs
(Hepatocyte growth factor regulated tyrosine kinase substrate,
Vps27 in yeast), which can also recruit the endosomal-associated
complex required for transport (ESCRT) I to endosomes,
through direct interaction with TSG101 (Vps23 in yeast;
for review see Clague and Urbe, 2003). Hrs is recruited to
the endosome in a complex with signal transducing adaptor
molecule (STAM)/Hrs binding protein, Hse1 in yeast. At
the endosome it is concentrated in regions covered with a
“bilayered” clathrin coat through direct interaction with
clathrin (Raiborg et al., 2001; Sachse et al., 2002), where it
may serve to concentrate ubiquitinated receptors before
inward vesiculation (Urbé et al., 2003).
The Hrs binding partner STAM was initially identified as
a mediator of interleukin stimulated myc induction and cell
proliferation (Asao et al., 1997). Two further STAM binding
partners have been identified, the deubiquitinating enzyme
(DUB) UBPY (Naviglio et al., 1998; Kato et al., 2000)
and associated molecule with the SH3 domain of STAM
(AMSH; Tanaka et al., 1999). Both of these proteins associate
with the SH3 domain of STAM through a shared STAM-
binding PX(V/I)(D/N)RXXKP motif and must therefore be
mutually exclusive (Kato et al., 2000).
Deubiquitination itself is not mandatory for receptor sorting
to the yeast vacuole, as ubiquitin can confer sorting after being
fused in frame with a cargo protein (Reggiori and Pelham,
2001), but it is required for maintenance of the free ubiquitin
pool, upon which receptor trafficking depends. Depletion of
the yeast DUB, Doa4, leads to an arrest of receptor sorting
through depletion of free ubiquitin levels (Swaminathan et
al., 1999; Amerik et al., 2000; Dupre and Haguenauer-Tsapis,
2001). Just as coordinated kinase action requires the opposing
effect of phosphatases, ubiquitin ligation is opposed by multiple
DUB activities (Wilkinson, 2000; Wing, 2003). Two classes
of DUB enzymes have been characterized as cysteine pro-
teases; the ubiquitin COOH-terminal hydrolases family and
the ubiquitin specific proteases (UBP) family of which Doa4
and UBPY are members.
Recently, a new family of isopeptidase DUB enzymes has
been predicted on the basis of a shared JAB1/MPN/Mov34
metalloenzyme (JAMM) motif (Hochstrasser, 2002; Maytal-
Kivity et al., 2002). The DUB activity of the proteasome recy-
cles ubiquitin and is coupled to protein degradation. It has
been linked to the JAMM-containing Rpn11/POH1 subunit
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of the 19S proteasome lid, through mutational analysis and
sensitivity to metal chelating agents (Verma et al., 2002; Yao
and Cohen, 2002). Isopeptidase activity amongst the JAMM
family is not confined to ubiquitin; the Jab1/Csn5 subunit of
the COP9 signalosome has been implicated in cleavage of
Nedd8 from Cul1 (Cope et al., 2002; Cope and Deshaies,
2003) and the motif is also present in eubacteria and archaea-
bacteria which do not possess ubiquitin (Maytal-Kivity et al.,
2002). Definitive biochemical evidence for direct association
of the JAMM domain–containing proteins with enzymatic
activity has been lacking as no activity has so far been found
with purified proteins outside of their respective multicompo-
nent complexes. The structure of a JAMM motif–containing
protein AfJAMM, from 
 
Archaeoglobus fulgidus
 
, has recently
been independently determined by two groups (Tran et al.,
2003; Ambroggio et al., 2004), revealing a fold that resembles
cytidine deaminase and an active site architecture that is
shared with thermolysin, placing the JAMM domain in a su-
perfamily of metal-dependent proteases.
AMSH contains a JAMM motif. In this paper, we have
characterized a Zn
 
2
 
 
 
-dependent ubiquitin isopeptidase ac-
tivity of purified AMSH in vitro, which displays distinct
properties from UBPY. Our data also indicate a functionally
significant association of AMSH with endosomes that influ-
ences the rate of EGF receptor (EGFR) degradation.
 
Results and discussion
 
AMSH shows deubiquitinating activity in vitro
 
We provide the first direct demonstration of isopeptidase ac-
tivity attributable to an isolated JAMM-containing protein.
GST-AMSH and GST-UBPY, purified from 
 
E. coli
 
, were
incubated with K48-linked tetra-ubiquitin (Fig. 1 a). DUB
activity is reported by the generation of lower denomination
forms of ubiquitin (mono-, di-, and tri-ubiquitin) resulting
from cleavage of the amide bond between K48 and the
COOH-terminal glycine of a linked ubiquitin. The cysteine
protease UBPY showed modest DUB activity toward tetra-
ubiquitin at physiological pH of 7.2 (unpublished data) but
efficiently generated mono-ubiquitin at pH 8.3 as character-
ized previously (Naviglio et al., 1998; Hartmann-Petersen et
al., 2003). AMSH possessed similar DUB activity at both
pH values; we therefore routinely used pH 7.2 with this en-
zyme. UBPY provides for complete breakdown of the tetra-
ubiquitin chain into component monomers of ubiquitin.
Remarkably, AMSH produces barely detectable levels of
mono-ubiquitin, but preferentially generates di-ubiquitin by
a single cleavage of the tetra-ubiquitin chain (Fig. 1 a).
Other DUB enzyme families are cysteine proteases and
consequently sensitive to the alkylating agent NEM. We
found AMSH activity was inhibited by 
 
N
 
-ethylmaleimide
(NEM) treatment (Fig. S1 c, available at http://www.jcb.org/
cgi/content/full/jcb.200401141/DC1), and also inhibited by
zinc chelating agents (Fig. 1 b), as expected for a metallopro-
tease. Although we do not expect the requirement of a cata-
lytic cysteine for AMSH activity, we note the presence of cys-
teine residues within the JAMM domain of AMSH, through
which NEM may exert an inhibitory effect.
We next used K63-linked and K48-linked chains of het-
erogeneous length as substrate to probe for linkage-depen-
dent specificity. Although K48-linked polyubiquitin specifies
proteasomal degradation, K63 linkages have been linked to
DNA repair mechanisms and to the endocytic pathway
(Dupre and Haguenauer-Tsapis, 2001; Schnell and Hicke,
2003). AMSH completely processed the K63 chains to
mono-ubiquitin, but was unable to process the K48 chains
(Fig. 1 c). This surprising failure to process the K48-linked
chains may reflect the presence of di-ubiquitin in the starting
mixture, which may then exert product inhibition properties
consistent with the data of Fig. 1 a. Remarkably, UBPY
demonstrated a completely opposite specificity; no activity
against K63 linkages and full processing of the K48 chains
(Fig. 1 c). A point mutation (D348A) of a conserved aspar-
tate residue within the JAMM domain of AMSH, ablated
Figure 1. Characterization of AMSH in vitro 
deubiquitinating activity and comparison with 
UBPY. (a) Tetra-ubiquitin chains (Ub4, 250 ng) 
were treated for 18 h at 37 C at pH 8.3 (lanes 1, 2, 
and 4) or pH 7.2 (lanes 3, 5, and 6) with AMSH or 
UBPY as indicated. (b) Tetra-ubiquitin chains were 
incubated with or without AMSH that was either 
left untreated or pretreated with respective vehicle 
(10% EtOH or 0.5% MeOH)   one of N,N,N-
tetrakis (2-pyridylmethyl) ethylenediamine (TPEN), 
1,10-phenanthroline (1 mM), or its nonchelating 
orthologue 1,7-phenanthroline (1 mM) for 30 min 
at 30 C. (c) 500 ng K63-linked and K48-linked 
polyubiquitin chains of heterogeneous lengths were 
incubated for 4 h without addition (lanes 2 and 6) 
with AMSH (lane 3), AMSH (D348A; lane 4) or 
UBPY (lane 5 and 7) either at pH 7.2 (lanes 2–5) or 
pH 8.3 (lanes 6 and 7). UBPY showed no activity 
against K63-chains, whereas AMSH generates 
mono-ubiquitin. UBPY shows isopeptidase activity 
against K48-linked chains, but AMSH does not, 
possibly due to the presence of Ub2 in the starting 
material. 
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enzymatic activity toward both K63-linked polyubiquitin
and K48-linked tetra-ubiquitin (Fig. 1 c and Fig. S1 b).
 
Expression of AMSH (D348A) leads to accumulation of 
endosomal ubiquitin
 
GFP-AMSH showed marked nuclear, cytosolic, and some
plasma membrane labeling as well as association with a few
dispersed punctae (Fig. 2). The strong nuclear localization of
AMSH is consistent with its possession of a nuclear localiza-
tion sequence. A cytosolic localization of epitope-tagged
AMSH has also been described previously (Itoh et al.,
2001). The association with punctae was much more pro-
nounced following expression of the enzymatically inactive
mutant GFP-AMSH (D348A; Fig. 2). Punctae correspond
to endosomes as judged by colocalization with EEA1 (Fig. 2
a, C and D), internalized biotin-EGF (Fig. 2 b, C and D),
and to a lesser degree with recycling endosomes (Fig. 2 a, E
and F transferrin receptor at steady state). Expression of cat-
alytically inactive AMSH (D348A) led to an accumulation
of ubiquitin on endosomes that clearly exceeds the levels
seen in nontransfected cells and cells overexpressing wild-
type AMSH (Fig. 2 b, E and F). Furthermore, the endoso-
mal protein Hrs, which contains a ubiquitin interaction
motif (UIM), was recruited to these punctae and corre-
spondingly depleted from the cytosol (Fig. S2, available at
http://www.jcb.org/cgi/content/full/jcb.200401141/DC1).
 
AMSH–STAM interaction
 
We have confirmed a previously reported interaction be-
tween AMSH and STAM (Kato et al., 2000), a protein
Figure 2. Colocalization of AMSH with endosomal markers. (a) AMSH partially localizes to endosomes. HeLa cells were transfected with 
GFP-AMSH (A, C, E, and G) or catalytically inactive mutant GFP-D348A (B, D, F, and H), and costained with anti-EEA1 (C and D) and anti-
transferrin receptor (TfR; E and F). (b) Catalytically inactive AMSH leads to accumulation of ubiquitin on endosomes. HeLa cells were transfected 
as in panel a, serum starved, stimulated for 30 min with 100 ng/ml biotinylated EGF (bEGF) and costained with anti-ubiquitin (E and F, FK2) 
and AF594-Neutravidin (C and D). All panels represent confocal sections. Colocalization of all three markers appears as white in overlays. 
Insets show threefold magnification of boxed areas. Bars, 10  m. 
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which is in dynamic equilibrium between cytosol and endo-
somal membranes. Co-immunoprecipitation was observed
following coexpression of GFP-AMSH and HA-STAM in
HeLa cells (Fig. 3 a). Expression of an inactive mutant GFP-
AMSH (D348A) led to a marked increase in this association
(Fig. 3 b). We also noticed that this mutant stabilized a mi-
nor form of total STAM that runs at a higher molecular mass
(Fig. 3 c), is enriched in the bound fraction and can be de-
tected with an anti-ubiquitin antibody (Fig. 3 d). STAM
contains a UIM domain, which has been shown to both bind
ubiquitin and specify mono-ubiquitination of endocytic pro-
teins which contain this motif (Polo et al., 2002, 2003). A
double point mutation in the UIM domain of STAM
(L176A/S177A) reverses the enhanced interaction with AMSH
(D348A) and the accumulation of the ubiquitinated higher
molecular mass form of STAM (Fig. 3, c and d).
This leads us to propose that on top of the well-charac-
terized interaction of the SH3-domain of STAM with
AMSH, there are further interactions that are contingent
on an intact STAM-UIM domain, which are only apparent
with enzymatically inactive AMSH. We suggest this may
be due to the UIM-dependent addition of an AMSH sub-
strate (e.g., ubiquitin or ubiquitin-like molecule) onto
STAM, which would normally be cleaved, either by ac-
tive AMSH or UBPY, but will simply provide an addi-
tional binding site for enzymatically inactive AMSH. The
D348A mutant of AMSH may therefore act as a “sub-
strate-trap” mutant, analogous to catalytically inactive mu-
tants of tyrosine phosphatase enzymes (Flint et al., 1997),
by displacing both endogenous AMSH and UBPY, which
share a binding site on STAM.
 
Short interfering RNA (siRNA) knockdown of AMSH 
accelerates EGFR down-regulation
 
An endosome-associated DUB may be expected to influence
trafficking of ubiquitinated receptors. We used siRNA to spe-
cifically knockdown AMSH in HeLa cells (Fig. 4, a–c). If
Figure 3. Catalytically inactive AMSH induces the accumulation 
of ubiquitinated STAM. (a) Lysates prepared from HeLa cells 
cotransfected with HA-STAM (or empty vector, V) and GFP-AMSH, 
were immunoprecipitated with anti-GFP and associated STAM de-
tected by immunoblotting with anti-HA. (b) Cells were cotransfected 
with HA-STAM (or empty vector, V) and GFP-AMSH (A), GFP-D348A 
(D), or GFP alone (V). Lysates from these cells were subjected to 
immunoprecipitation either with anti-GFP or anti-HA antibodies and 
associated STAM (arrow) and D348A-AMSH (arrow) were detected 
by immunoblotting as indicated. (c) Cells were cotransfected with 
HA-STAM or HA-LSAA (UIM point mutant) and GFP-AMSH (A), 
GFP-D348A (D), or GFP alone (V). Lysates from these cells were sub-
jected to immunoprecipitation as in panel b and the bound fractions 
and lysates were analyzed by immunoblotting as indicated. Note the 
appearance of a high molecular mass band in lanes 2 and 6 in the 
darker exposure (second panel). (d) Cells were transfected as in panel 
c and subjected to immunoprecipitation with anti-GFP and anti-HA 
antibodies followed by immunoblotting as indicated.
Figure 4. AMSH knockdown by siRNA enhances 
the rate of EGFR down-regulation. HeLa cells 
subjected to 48 h of treatment with either nonspecific 
control or AMSH-specific siRNA were serum starved 
and stimulated for the indicated times with 100 
ng/ml EGF. (a) Lysates were analyzed by immuno-
blotting with anti-EGFR, and sequentially with 
anti-AMSH and antitubulin (arrow indicates AMSH 
signal). (b) Graphic representation of anti-EGFR 
data shown in panel a. Open squares, control; 
closed circles, AMSH. (c) Relative EGFR-down-
regulation in control (unshaded bars) and AMSH 
siRNA cells (shaded bars). Error bars show SD 
(n   4). (d) AMSH deubiquitinates EGFR in vitro. 
In vitro activity of AMSH on immunoprecipitated 
EGFR. Her14 cells were serum starved, stimulated 
for 10 min with 100 ng/ml EGF, and lysed. Ubiquiti-
nated EGFR was isolated by immunoprecipitation 
and used as a substrate in an in vitro deubiquitination 
assay (18 h, 37 C) in the presence or absence of 1  M 
AMSH or catalytically inactive AMSH (D348A). 
Samples were analyzed by immunoblotting with 
anti-ubiquitin (P4G7) antibody, and reprobed with 
anti-EGFR. 
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AMSH influences the dynamics of EGFR trafficking through
deubiquitination, then it should alter the rate of receptor deg-
radation following acute stimulation with EGF. We consis-
tently observed an increased rate of receptor degradation in
AMSH knockdown cells. The relative amount of receptor re-
maining after 30 min of stimulation compared with control
cells is 0.51 (
 
  
 
0.04, 
 
n 
 
  
 
4). A second siRNA duplex de-
signed to knockdown AMSH likewise enhanced the rate of
EGFR degradation (unpublished data). The E3-ligase Cbl has
been shown to promote EGFR degradation through ubiquiti-
nation of the receptor, which promotes lysosomal sorting at
the expense of recycling (Levkowitz et al., 1998; Thien and
Langdon, 2001). Endosomal DUBs, such as AMSH, could be
expected to reverse this modification and hence oppose lyso-
somal sorting. In support of this notion, we are able to
show that EGFR, immunoprecipitated from EGF-stimulated
Her14 cells, can be deubiquitinated by AMSH in vitro. Note
the smeary appearance of EGFR is due to multiple mono-
ubiquitination, rather than polyubiquitination (Haglund et
al., 2003; Mosesson et al., 2003), allowing us to infer that
mono-ubiquitin can provide a substrate for AMSH isopepti-
dase activity. Thus, knockdown of AMSH may enhance re-
ceptor degradation by removing an activity, which opposes
that of the relevant E3-ligase as illustrated in Fig. 5. Although
we cannot fully exclude effects on components of the sorting
machinery, we do not observe any appearance of additional
high molecular mass bands in AMSH knockdown cells for
Hrs nor for STAM, suggesting that in the absence of AMSH,
another DUB, possibly UBPY, controls the ubiquitination
status of STAM (Fig. S3, available at http://www.jcb.org/cgi/
content/full/jcb.200401141/DC1). In our proposed model
(Fig. 5), the action of AMSH precedes absolute commitment
of the receptor to the lysosomal pathway, allowing for the pos-
sibility that an alternative DUB such as UBPY may act to re-
cycle ubiquitin from receptors after sorting but before seques-
tration in lumenal vesicles, as has been proposed for Doa4 in
yeast (Amerik et al., 2000).
 
Concluding remarks
 
Our data is the first isopeptidase activity associated with a
purified JAMM domain protein. Clearly not all JAMM do-
main proteins are deubiquitinating enzymes as they appear
in evolution before development of the ubiquitin system.
Others require embedding in macromolecular complexes for
activity to be observed. AMSH DUB activity can be directed
against K63-linked ubiquitin and it is noteworthy that an-
other DUB, UBPY, is unable to process these chains. The
results presented here which demonstrate AMSH ubiquitin
isopeptidase activity toward ubiquitin chains and EGFR, an
influence upon endosomal ubiquitin levels and the rate of
acute down-regulation of the EGFR all point to a physiolog-
ical role for this activity.
 
Materials and methods
 
Plasmids
 
Human AMSH cDNA was purchased from Origene Technologies Inc., se-
quenced and subcloned into pGEX4T2 and pEGFP-C. The D348A muta-
tion was introduced by QuickChange Site-directed Mutagenesis (Strat-
agene). GST-UBPY and HA-STAM (pMIW-HA-Hbp) constructs were gifts
from G. Draetta (European Institute of Oncology, Milan, Italy) and N. Kita-
mura (Tokyo Institute of Technology, Yokohama, Japan), respectively. The
UIM point mutant L176/S177A was generated by PCR-based mutagenesis
using the following primers: 5
 
 
 
-gctaaagctattgaggcagcgttgcaagagcag-3
 
 
 
 and
5
 
 
 
-ctgctcttgcaacgctgcctcaatagctttagc-3
 
 
 
.
 
Antibodies and other reagents
 
Antibodies were purchased from Covance (HA, P4G7), Affinity Bio-
Reagents, Inc. (FK2), Roche (transferrin receptor), Santa Cruz Biotechnol-
ogy, Inc. (EGFR: RI and 1005), and Sigma-Aldrich (ubiquitin, tubulin).
Anti-GFP was a gift of F. Barr (Max Planck Institute of Biochemistry, Mar-
tinsried, Germany). Biotin-EGF and secondary antibodies were purchased
from Molecular Probes and Sigma-Aldrich. Rabbit polyclonal AMSH anti-
body was generated against the peptide MSDHGDVSLPPEDRV (CovalAb).
Rabbit polyclonal EEA1 and Hrs antibodies have been described previ-
ously (Mills et al., 1998; Sachse et al., 2002). Her14 cells (stably trans-
fected with human EGFR) were provided by E. Klapisz (Institute of
Biomembranes, University of Utrecht, Utrecht, Netherlands).
 
Immunofluorescence
 
Transfected cells were processed 24 h after transfection for immunofluo-
rescence as described previously (Urbé et al., 2003). Dual stained confo-
cal images were taken with a Laser-Sharp confocal microscope (Bio-Rad
Laboratories; 63x Planapo1.4 oil objective; Carl Zeiss MicroImaging, Inc.).
Triple-labeled samples were stained with AF594 and 633 coupled second-
ary antibodies and analyzed with a confocal SP2 AOBS (Leica; HCX PL
APO CS 63.0 
 
 
 
 1.40 oil objective).
 
Bacterial expression and purification of recombinant proteins
 
GST-AMSH, -D348A, and -UBPY were expressed in Rosetta (DE3) pLysS
cells (Novagen) and batch purified with glutathione-Sepharose (Amersham
Biosciences) according to the manufacturer’s instructions.
Figure 5. Proposed model for AMSH function: AMSH promotes 
EGFR recycling by opposing Cbl E3-ligase activity. The model 
illustrates the proposed physiological role of AMSH on endosomes: 
phosphorylated EGFR recruits the E3-ligase c-Cbl, which mediates 
its ubiquitination. Ubiquitinated EGFR is sequestered by the endo-
somal Hrs/Clathrin coat, following which further ubiquitin-mediated 
interactions with components of the ESCRT machinery (not depicted) 
lead to translocation into internal vesicles of the multivesicular 
body (MVB). AMSH counteracts Cbl activity through deubiquitination 
of EGFR and will therefore favor recycling of the receptor. In this 
model, the relative kinetics, after ubiquitination, of commitment 
to inclusion in an inwardly budding vesicle and deubiquitination 
determine the itinerary of the receptor. 
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Deubiquitination assay
 
K48-linked tetra-ubiquitin (250 ng) or K48-linked polyubiquitin chains (500
ng), purchased from Affinity BioReagents, Inc., or K63-linked polyubiquitin
chains (500 ng; Boston Biochem) were incubated at 37
 
 
 
C for 4 or 18 h in
DUB buffer (50 mM Tris-HCl, pH 7.2 or pH 8.3, 25 mM KCl, 5 mM MgCl
 
2
 
,
1 mM DTT) with or without GST-AMSH, GST-D348A, or GST-UBPY in 20
 
 
 
l. The reaction was stopped by holding at 4
 
 
 
C for 10 min, followed by ad-
dition of SDS sample buffer. Ubiquitinated EGFR was immunoprecipitated
from lysates (25 mM Tris, pH 7.2, 100 mM NaCl, 50 mM NaF, 0.5% NP-40,
10 mM NEM, phosphatase inhibitor cocktail II; Sigma-Aldrich) prepared
from starved or EGF-stimulated Her14 cells, washed, and incubated for
18 h in DUB-buffer, pH 7.2, with AMSH added as indicated.
 
Detection of ubiquitin
 
Proteins were resolved by 15% SDS-PAGE for 3 h at 90 V with a Tris-gly-
cine–based anode buffer and a Tris-tricine–based cathode buffer. Gels
were soaked in 2.3% SDS, 5% 
 
 
 
-mercaptoethanol, 63 mM Tris-HCl, pH
6.8, for 30 min. Resolved proteins were transferred to nitrocellulose (0.2
 
 
 
m) for 45 min in 25 mM 3-(cyclohexylamino)-1-propane-sulfonic acid,
pH 10, 20% methanol. The membrane was boiled for 30 min in de-ion-
ized water, blocked in 0.5% fish gelatin, 0.1% Tween 20 in PBS and
probed with a rabbit antibody to ubiquitin (Sigma-Aldrich) followed by
ECL-based detection.
 
Cotransfection and immunoprecipitation
 
HeLa cells were transfected with Genejuice (Novagen) and lysed 24 h after
transfection. Immunoprecipitations were performed as described previ-
ously (Urbé et al., 2003).
 
Depletion of cellular AMSH by siRNA
 
HeLa cells were treated 24 h after seeding with either control siRNA du-
plex (nonspecific control VII) or AMSH-specific siRNA duplex (sense 5
 
 
 
-
UUACAAAUCUGCUGUCAUUUU-3
 
 
 
; antisense 5
 
 
 
-PAAUGACAGCAGA-
UUUGUAAUU-3
 
 
 
; Dharmakon) at 44.3 nM concentration using Oligo-
fectamine in the absence of serum (Invitrogen). 4 h after transfection, FBS
was added to a final concentration of 10%.
 
Online supplemental material
 
Fig. S1 is a comparison of GST-AMSH and GST-D348A activity on tetra-
ubiquitin chains and shows that AMSH activity is sensitive to NEM. Fig. S2
shows the redistribution of Hrs by catalytically inactive AMSH. In Fig. S3,
AMSH siRNA knockdown does not affect the expression levels of Hrs and
STAM. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200401141/DC1.
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